Latest News & Features
Americas
US-based Acorda Therapeutics has sued Actavis for infringing four patents covering its multiple sclerosis (MS) drug Ampyra (dalfampridine). 9 July 2014
Asia
Australian biotechnology company NeuClone has signed an agreement with vaccine maker the Serum Institute of India to manufacture and supply ten biosimilar monoclonal antibody drugs around the world. 8 July 2014
Generics
The PharmaSea project is working to make viable drug candidates of novel compounds found under the sea. LSIPR discovers how the EU-funded initiative does it. 7 July 2014
Biotechnology
The EPO generally accepts applications relating to human embryonic stem cells with an effective date after 2008 but discussions about eligibility continue, says Joachim Wachenfeld. 7 July 2014
Americas
An ex-employee for a large Chinese seed production company has been arrested in the US for conspiring to steal trade secrets from US agricultural companies including Monsanto. 7 July 2014
Asia-Pacific
Personal health records company MMR Global has entered into a licensing agreement with Australian medical database company Claydata. 7 July 2014
Americas
Pfizer has launched a lawsuit against Aurobindo Pharma accusing the Indian pharmaceutical company of infringing patents related to an antibiotic used to treat skin infections. 4 July 2014
Americas
Actavis’s newly-acquired subsidiary Forest Laboratories has bought drug development company Furiex Pharmaceuticals for $1.1 billion. 3 July 2014
Americas
The head of IP at a major pharmaceutical company is set to be named as the next director of the US Patent and Trademark Office, reports have claimed. 2 July 2014
Americas
Genentech has entered into an agreement to buy Seragon, a San Diego-based biotech company that specialises in developing treatments that target hormone-driven cancers, for up to $1.7 billion. 2 July 2014